Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HepaGam B effect on blood glucose monitoring
NCT00998426Phase 4Completed
- Sponsor
- Georgetown University
- Start
- Oct 2009
- Primary completion
- Sep 2011
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis B immune globulin in hepatitis B (HBV), sponsored by Georgetown University. Started Oct 2009; status: completed.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00998426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00998426.